Suppressor T Cells Induced in Vivo by Tolerogenic Conjugates of a Given Antigen and Monomethoxypolyethylene Glycol Downregulate Antibody Formation Also to a Second Antigen, if the Latter is Presented as a Covalent Adduct with the Former
Recent results of studies employing tolerogenic monomethoxypolyethylene glycol (mPEG) conjugates of antigens are briefly reviewed. Administration of antigen(mPEG)n conjugates into mice induced antigen specific suppressor T (Ts) cells, from which a suppressor factor (TsF) was extracted. These Ts cells were cloned and shown to be Thyl.2+, CD3+, CD4−, CD5−, CD8+ and to express the αβ heterodimer of conventional T cell receptors (TCR). The TsF of a clone of OVA-specific Ts cells shared the epitopes of the α and β chains of TCR, whereas the TsF of T cells of an HIgG-specific clone shared only the epitope of the α chains of TCR; OVA and HIgG represent ovalbumin and human monoclonal (myeloma) IgG. These studies have provided evidence for the phenomenon of “linked immunological suppression” which may be summarized by the statement “Ts cells specific for an epitope of a given antigen, AgA, suppress the antibody response to an unrelated antigen, AgB, only if the latter is presented in the form of a covalent adduct, AgA-AgB, to the immune system of the animal pretolerized with AgA (mPEG)n, but not if AgB is presented as a mixture with AgA.
KeywordsAntibody Response Antigen Present Cell Covalent Adduct ELISA Titre Syngeneic Recipient
Unable to display preview. Download preview PDF.
- Cruse, J. M. and Lewis, R. E., Jr., eds., 1989, “Therapy of autoimunne diseases,” Karger, Basel.Google Scholar
- Diamantstein, T. and Osawa, H., 1986, The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies, in: “Immunol. Rev.,” 92:5, G. Möller, ed., Munksgaard, Copenhagen.Google Scholar
- Frankel, A. E., 1988, “Immunotoxins,” Kluwer Academic Publishers, Boston.Google Scholar
- Katre, N. V., 1990, Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol, J. Immunol., 144:144.Google Scholar
- Mokashi, S., Holford-Strevens, V., Sterrantino, G., Jackson, C-J. C., and Sehon, A.H., 1989, Down-regulation of secondary in vitro antibody responses by suppressor T cells of mice treated with a tolerogenic conjugate of ovalbumin and monomethoxypolyethylene glycol, OVA(mPEG)13, Immunol. Lett., 23:95.PubMedCrossRefGoogle Scholar
- Sedlacek, H. H., Schulz, G., Steinstraesser, A., Kuhlmann, L., Schwarz, A., Seidel, L., Seemann, G., Kraemer, H. P., and Bosslet, K., 1988, “Monoclonal antibodies in tumor therapy — Present stage, chances and limitations,” Karger, Basel.Google Scholar
- Sehon, A., 1989, Modulation of antibody responses by conjugates of antigens with monomethoxypolyethylene glycol, in: “Immunobiology of proteins and peptides V”, M. Z. Atassi, ed., Plenum Publishing Corporation, New York.Google Scholar
- Vogel, C-W., 1987, �x201C;Immunoconjugates: Antibody Conjugates in Radioimaging and Therapy of Cancer”, Oxford University Press, Oxford.Google Scholar